Diagnostic testing plays a crucial role in animal healthcare, offering veterinarians a diverse range of tests for disease identification and monitoring. The efficacy of diagnostic testing relies on swift, reliable, and accurate methods, facilitating informed diagnoses.
Despite various challenges, the veterinary diagnostics market has shown consistent growth and is forecasted to continue on this trajectory. This sector presents a rapidly expanding market opportunity for in vitro diagnostic (IVD) companies and others who can leverage the ongoing demand to ensure agricultural productivity and address the rise in consumer spending on companion animals.
The World Market for Veterinary Diagnostics, 7th Edition meticulously examines the global veterinary diagnostics market, focusing on two key components: companion animal (pets) diagnostics and food animal diagnostics.
The report provides a comprehensive analysis of major veterinary disease markets, offering insights into overall market performance and development. Key data points include:
Total Global Animal Diagnostic Testing Market, 2023-2028 (in millions $ at manufacturer level)
Global Veterinary Diagnostic Testing Market Share by Region, 2023 (US, Europe, Latin America, Asia Pacific, RoW)
The World Market for Veterinary Diagnostics contains the following market data points for both the food animal and companion animal segments:
Global Animal Diagnostic Testing Market by Animal Segment, 2023-2028
Veterinary Companion Diagnostics Market Segmentation, 2023 (Clinical Chemistry, Molecular Assays and Instruments, Non-Infect Immunodiagnostics, and Other Analyzers and Reagents)
Market Size and Growth for United States Diagnostic Testing Market, 2023-2028
Market Size and Growth for European Diagnostics Testing Market (France, Germany, Italy, Netherlands, Spain, Switzerland, United Kingdom, Rest of Europe), 2023-2028
Market Size and Growth for Asia Pacific Diagnostic Testing Market (Australia, China, Japan, Rest of Asia Pacific), 2023-2028
Market Size and Growth for Latin America Companion Animal Diagnostic Testing Market (Brazil, Mexico, Rest of Latin America), 2023-2028
Market Size and Growth for Rest of World Diagnostic Testing Market (including Canada), 2023-2028
RoW Companion Animal Diagnostic Testing by Country Percent, 2023
Key Topics Covered:
Chapter 1: Executive Summary
Veterinary Diagnostic Technologies and Products
Size and Growth of the Market
Scope and Methodology
Competitive Landscape
Chapter 2: Veterinary Diagnostic Products
Background
Diagnostic Methods
Immunodiagnostics
Elisa/Celisa
Lateral Flow Tests
Non-Infectious Immunoassays
Fluorescent Antibody
Indirect Fluorescent Antibody
Complement Fixation
Agar Gel Immunodiffusion
Agglutination
Serum/Virus Neutralization
Immunohistochemistry
Microbiology
Molecular Tests
PCR/QPCR
Blots
Microarrays
Sequencing
Clinical Chemistry
Urinalysis
Hematology
Major Veterinary Diseases
Leading Licensed Tests
Chapter 3: Companion Animal Diagnostics Market
Market Size and Growth
Regional Analysis
United States
Europe
Asia-Pacific
Latin America
Rest of World
Market Factors
POC Diagnostics
COVID-19
Veterinary Telemedicine
Veterinary Visits and Laboratory Requisitions
Veterinary Staffing Issues
Veterinary Colleges Step Up
Equine Care is Challenging
Long-Term Trends in Companion Animal Healthcare
End-users
Regulation
Chapter 4: Food Animal Diagnostics Market
Regional Analysis
Europe
United States
Asia-Pacific
Latin America
Rest of World
Market Factors
Food Animal Diagnostics in an Age of Globalization
Staffing
End-user Markets and Advancements
Regulation
Chapter 5: Total Global Market Analysis and Competitive Market Shares
Major Veterinary Diseases
Market Performance and Development
Market Factors
Drivers and Limiters of the Veterinary Diagnostic Market
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
With the Pandemic Accord negotiations set to resume tomorrow for a last-ditch effort to find consensus before the deadline at the end of May, AIDS Healthcare Foundation (AHF) has described the current state of the text as 20% equity and 80% inequity....
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES/
Accretive acquisition of select assets in Southeast and Southwest...
Jolt Health Inc. ("JOLT" and or "the Company") is pleased to announce an arms-length agreement dated April 16, 2024 to acquire intellectual property to develop transdermal delivery technology for chloroquine and...
NioCorp Developments Ltd. ("NioCorp" or the "Company") announces that it has received a preliminary, non-binding indicative financing term sheet from the Export-Import Bank of the United States ("EXIM") as part of a...
Achieves first quarter targets, increases guidance
Q1 2024 Highlights:
Free Cash Flow of $102.1 million, compared to $73.1 million for Q1 2023, primarily derived from operating cash flows and net proceeds of $38.0 million related to the sale of two...
Medical Properties Trust, Inc. (the "Company" or "MPT") today issued the following statement in response to Steward Health Care's decision to commence an in-court restructuring process under Chapter 11 of the U.S. Bankruptcy Code.
MPT has approved...